Progressive multifocal leukoencephalopathy, also known as PML is a problem which can affect a select number of patients with multiple sclerosis as well as other conditions which involve the immune system. What can be done to address the condition is still being determined by the medical community.
“Multiple sclerosis usually begins with a relapsing-remitting (RRMS) phase characterized by clinical relapses and inflammatory demyelination evident on magnetic resonance imaging (MRI),” an Ohio based team began at ECTRIMS 2016.
Multiple sclerosis is perceived differently by the patient and physician – after all, they’re in two different boats. However, this disconnect could make managing the disease a more complicated journey.
The treatment of multiple sclerosis has come a long way in recent years. However, there is a lot more to be done. There is optimism that over time treatment can be even more effective and help even more patients as new treatment methods are developed.
Patients diagnosed with relapsing remitting multiple sclerosis have seen their treatment options increase dramatically in recent years. Now patients with the progressive forms are seeing the the start of momentum building in their favor.
For those with type 2 diabetes who reside in rural communities, distance from large medical centers and research universities may limit their access to new ideas and programs. The result may be poorer disease management and less physical activity than is reasonable or necessary. Welcome: mobile apps.
On 9/11/01 Manuel Delgado was a paramedic caring for patients at the base of the south tower. Delgado shares his first hand account of the attack on the building, patient care, survival, and the implications of events of the day on paramedic practice in New York City.